Importance of Lymph Node Involvement in Pancreatic Neuroendocrine Tumors: Impact on Survival and Implications for Surgical Resection

被引:71
|
作者
Curran, Thomas [1 ]
Pockaj, Barbara A. [2 ]
Gray, Richard J. [2 ]
Halfdanarson, Thorvardur R. [3 ]
Wasif, Nabil [2 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA
[2] Mayo Clin Arizona, Sect Surg Oncol, Dept Surg, Phoenix, AZ 85054 USA
[3] Mayo Clin Arizona, Dept Med Oncol, Phoenix, AZ USA
关键词
Pancreatic neuroendocrine tumor; Lymph node; Survival surgery; PROGNOSTIC-FACTORS; ENDOCRINE TUMORS; SYSTEM;
D O I
10.1007/s11605-014-2624-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Conflicting data exist on predictors of nodal metastases and their impact on survival in patients with pancreatic neuroendocrine tumors (PNETs). We aim to identify factors associated with lymph node involvement and evaluate the effect of nodal metastases on survival. Methods All patients undergoing surgery for PNETs in the Surveillance, Epidemiology, and End Results (SEER) tumor registry from 1988 to 2010 were included. Predictors of lymph node involvement and disease-specific survival (DSS) were evaluated using logistic regression and Cox regression, respectively. Results Patients (1,915) underwent surgery for a PNET (62 % nonfunctional). Nodal positivity was associated with increasing tumor size (p<0.001) and grade (p<0.001). Unadjusted DSS at 5 years was 81 % for N0, 74 % for Nx, and 69 % for N1, respectively, (p<0.001). After adjustment for tumor size and grade, DSS was significantly decreased in N1 patients (HR 1.57; 95 % CI 1.23-1.95). For patients who had at least one node examined and had low-grade PNETs <1 cm, no nodal metastases were found. Conclusions High tumor grade and increasing size predict nodal metastases in patients with PNETs. N1 status is independently associated with decreased DSS. Low-grade tumors <1 cm may be observed or enucleated.
引用
收藏
页码:152 / 160
页数:9
相关论文
共 50 条
  • [31] Impact of para aortic lymph node removal on survival following resection for pancreatic adenocarcinoma
    Martin Sillesen
    Carsten Palnæs Hansen
    Stefan Kobbelgaard Burgdorf
    Emilie Even Dencker
    Paul Suno Krohn
    Sophie Louise Gisela Kollbeck
    Mogens Tornby Stender
    Jan Henrik Storkholm
    BMC Surgery, 23
  • [32] Pancreatic neuroendocrine tumors: Surgical outcomes and survival analysis
    Fahmy, Joseph N.
    Varsanik, M. Alyssa
    Hubbs, Daniel
    Eguia, Emanuel
    Abood, Gerard
    Knab, Lawrence M.
    AMERICAN JOURNAL OF SURGERY, 2021, 221 (03): : 529 - 533
  • [33] Surgical Resection Provides a Significant Overall Survival Benefit for Patients With Small Pancreatic Neuroendocrine Tumors
    Sharpe, Susan
    In, Haejin
    Winchester, David P.
    Talamonti, Mark
    Baker, Marshall
    GASTROENTEROLOGY, 2014, 146 (05) : S1027 - S1027
  • [34] Pancreatic Neuroendocrine Tumors (panNETs): Analysis of Overall Survival of Nonsurgical Management Versus Surgical Resection
    Finkelstein, Paige
    Sharma, Rishika
    Picado, Omar
    Gadde, Rahul
    Stuart, Heather
    Ripat, Caroline
    Livingstone, Alan S.
    Sleeman, Danny
    Merchant, Nipun
    Yakoub, Danny
    JOURNAL OF GASTROINTESTINAL SURGERY, 2017, 21 (05) : 855 - 866
  • [35] Pancreatic Neuroendocrine Tumors (panNETs): Analysis of Overall Survival of Nonsurgical Management Versus Surgical Resection
    Paige Finkelstein
    Rishika Sharma
    Omar Picado
    Rahul Gadde
    Heather Stuart
    Caroline Ripat
    Alan S. Livingstone
    Danny Sleeman
    Nipun Merchant
    Danny Yakoub
    Journal of Gastrointestinal Surgery, 2017, 21 : 855 - 866
  • [36] Pancreatic Neuroendocrine Tumors (PNETs): Survival Analysis Comparing Surgical Resection Versus Non-Surgical Management
    Finkelstein, P.
    Picado, O.
    Gadde, R.
    Sharma, R.
    Merchant, N.
    Yakoub, D.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S169 - S170
  • [37] THE STRATEGY OF THE TREATMENT FOR PANCREATIC NEUROENDOCRINE TUMORS WITH LIVER OR LYMPH NODE METASTASES
    Nakayama, Shun
    Ottomo, Shigeru
    Yoshida, Hiroshi
    Motoi, Fuyuhiko
    Rikiyama, Toshiki
    Katayose, Yu
    Egawa, Shinichi
    Unno, Michiaki
    ANNALS OF ONCOLOGY, 2011, 22 : v68 - v68
  • [38] A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine Tumors
    Osher, Esther
    Shalabna, Eiman
    Klausner, Joseph M.
    Greenman, Yona
    Stern, Naftali
    Shibolet, Oren
    Scapa, Erez
    Yakir, Oz
    Shor, Dana Ben-Ami
    Bar-Yishay, Iddo
    Shamai, Sivan
    Sofer, Yael
    Lubezky, Nir
    Goykhman, Yaacov
    Lahat, Guy
    Wolf, Ido
    Pelles, Sharon
    Aizic, Asaf
    Blachar, Arye
    Geva, Ravit
    BIOMEDICINES, 2023, 11 (02)
  • [39] SIZE OF PANCREATIC NEUROENDOCRINE TUMORS CORRELATES WITH RISK OF LYMPH NODE METASTASIS
    Michelakos, Theodoros
    Marchegiani, Giovanni
    Fernandez-Del Castillo, Carlos
    Honselmann, Kim C.
    Cai, Lei
    Miotto, Marco
    Landoni, Luca
    Warshaw, Andrew L.
    Lillemoe, Keith D.
    Bassi, Claudio
    Ferrone, Cristina R.
    GASTROENTEROLOGY, 2017, 152 (05) : S1250 - S1250
  • [40] Lymph Node Ratio and Para-Aortic Node Involvement Are Not Independent Predictors of Survival After Resection for Pancreatic Cancer
    Beltrame, Valentina
    Gruppo, Mario
    Valmasoni, Michele
    Merigliano, Stefano
    Sperti, Cosimo
    GASTROENTEROLOGY, 2016, 150 (04) : S1232 - S1232